Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Kura Oncology, Inc. | Chief Legal Officer | Common Stock | 69K | $1.53M | $22.15 | May 20, 2024 | Direct |
Kura Oncology, Inc. | Chief Legal Officer | Option to purchase common stock | 92.5K | Jan 2, 2024 | Direct | ||
Athenex, Inc. | General Counsel, SVP Admin. | Restricted Stock Units | 37.5K | Aug 3, 2021 | Direct | ||
Athenex, Inc. | General Counsel, SVP Admin. | Stock Option (Right to Buy) | 37.5K | Aug 3, 2021 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
KURA | Kura Oncology, Inc. | May 20, 2024 | 1 | -$57.9K | 4 | May 20, 2024 | Chief Legal Officer |
KURA | Kura Oncology, Inc. | Jan 29, 2024 | 1 | -$36.5K | 4 | Jan 31, 2024 | Chief Legal Officer |
KURA | Kura Oncology, Inc. | Jan 2, 2024 | 2 | $0 | 4 | Jan 4, 2024 | Chief Legal Officer |
KURA | Kura Oncology, Inc. | Feb 16, 2023 | 2 | $0 | 4 | Feb 21, 2023 | Chief Legal Officer |
KURA | Kura Oncology, Inc. | Nov 17, 2022 | 1 | -$32K | 4 | Nov 18, 2022 | Chief Legal Officer |
KURA | Kura Oncology, Inc. | Oct 18, 2021 | 1 | $0 | 4 | Oct 19, 2021 | Chief Legal Officer |
KURA | Kura Oncology, Inc. | Oct 18, 2021 | 0 | $0 | 3 | Oct 19, 2021 | Chief Legal Officer |
ATNXQ | Athenex, Inc. | Aug 3, 2021 | 2 | $0 | 4 | Aug 5, 2021 | General Counsel, SVP Admin. |